Novartis AG

Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS

Brolucizumab 6mg

Phase 3

Neovascular Age-Related Macular Degeneration

Ruxolitinib (RUX)

Phase 3

Corticosteroid Refractory Acute Graft vs Host Disease

Canakinumab 150 mg

Phase 3

Acute Gout

GP2017 (adalimumab biosimilar)

Phase 3

Ankylosing Spondylitis

Meningococcal ACWY conjugate vaccine

Phase 3

Bacterial Meningitis

Labeled regime arm

Phase 3

Diabetic Macular Edema

Fluticasone/salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

Aliskiren 75 mg

Phase 3

Hypertension

exemestane

Phase 3

Post Menopausal Breast Cancer

Bosentan

Phase 3

Pulmonary Arterial Hypertension

Long-acting beta 2-agonist (LABA)

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Valsartan + Amlodipine besilate

Phase 3

Hypertension

Budesonide

Phase 3

Asthma

Mycophenolic Acid (MPA)

Phase 3

Kidney Transplantation

First line DMT

Phase 3

Multiple Sclerosis

Iptcaopan 200 mg

Phase 3

Atypical Hemolytic Uremic Syndrome

Nilotinib

Phase 3

Gastrointestinal Stromal Tumors

Seasonal Influenza Vaccine

Phase 3

Influenza

Meningococcal B Recombinant vaccine rMenB+OMV NZ

Phase 3

Meningococcal Disease

Inclisiran

Phase 3

Familial Hypercholesterolemia - Homozygous

Everolimus and tacrolimus

Phase 3

Kidney Transplant

Famciclovir

Phase 3

Genital Herpes

Risedronate

Phase 3

Paget's Disease of Bone

Crizanlizumab (SEG101)

Phase 3

Sickle Cell Disease (SCD)

Pimecrolimus Cream 1%

Phase 3

Atopic Dermatitis

Daptomycin

Phase 3

Infections

VAL489

Phase 3

Pediatric Hypertension With or Without CKD

Salmeterol

Phase 3

Chronic Obstructive Pulmonary Disease

Prograf or Neoral

Phase 3

Kidney Transplantation

sacubitril/valsartan

Phase 3

Heart Failure With Preserved Ejection Fraction

Octreotide

Phase 3

Thymoma

Enalapril

Phase 3

Pediatric Heart Failure

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

NVA237 50 µg and indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ciclosporin

Phase 3

Severe Atopic Dermatitis

rofecoxib

Phase 3

Osteoarthritis

Pandemic influenza vaccine

Phase 3

Influenza

Secukinumab (150 mg)

Phase 3

Anklyosing Spondylitis

sulfonylurea (SU)

Phase 3

Type 2 Diabetes Mellitus (T2DM)

MMF

Phase 3

Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant

Octreotide acetate 30 mg suspension

Phase 3

Acromegaly

Losartan

Phase 3

Hypertension; Hypertrophy, Left Ventricular

[68Ga]Ga-PSMA-11

Phase 3

Prostatic Neoplasms

MF59-eH1N1

Phase 3

Influenza

Calcium and vitamin D supplements

Phase 3

Paget's Disease of Bone

MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)

Phase 3

Influenza

octreotide LAR 30mg

Phase 3

Acromegaly

Xylometazoline

Phase 3

Common Cold

Aliskiren 300 mg

Phase 3

Hypertension

AIN457 6 mg/kg i.v.

Phase 3

Psoriatic Arthritis

basiliximab

Phase 3

Liver Transplantation

valsartan+amlodipine combination

Phase 3

Hypertension

Remibrutinib

Phase 3

Relapsing Multiple Sclerosis

Telbivudine

Phase 3

Hepatitis B Virus

Meningococcal ACWY Polysaccharide Vaccine

Phase 3

Meningococcal Meningitis

Pimecrolimus

Phase 3

Atopic Dermatitis

Depigoid

Phase 3

Allergic Asthma

Bosutinib

Phase 3

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive

Rivastigmine 5 cm^2

Phase 3

Alzheimer Disease

simvastatin

Phase 3

Essential Hypertension

Secukinumab (75 mg)

Phase 3

Ankylosing Spondylitis

onasemnogene abeparvovec

Phase 3

Spinal Muscular Atrophy (SMA)

Leuprolide

Phase 3

Breast Cancer

brolucuzumab 6 mg IVT

Phase 3

Age-Related Macular Degeneration

Ofatumumab

Phase 3

Relapsing Multiple Sclerosis

Deferasirox

Phase 3

Beta-thalassemia

ACZ885 150 mg (Canakinumab)

Phase 3

Systemic Juvenile Idiopathic Arthritis (SJIA)

canakinumab

Phase 3

NALP3 Mutation

Candesartan+HCTZ - Phase 1

Phase 3

Hypertension

TRI476

Phase 3

Partial Onset Seizures

Ansastrozole

Phase 3

Early Breast Cancer

Aliskiren/amlodipine 300/10 mg tablet

Phase 3

Moderate to Severe Hypertension

HCD122

Phase 2

Non-Hodgkin's Lymphoma

Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)

Phase 2

Hormone Receptor Positive Breast Cancer

Conventional Therapy

Phase 2

Non-infectious Intermediate Uveitis

Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Meningococcal (group B) multicomponent recombinant adsorbed vaccine.

Phase 2

Meningococcal Disease

GSK2110183 (afuresertib)

Phase 2

Cancer

Octreotide (Immediate release)

Phase 2

Peritoneal Neoplasms

TMZ

Phase 2

Medulloblastoma

decitabine

Phase 2

Myelodysplastic Syndromes

QAV680

Phase 2

Seasonal Allergic Rhinitis

Midostaurin (PKC412)

Phase 2

Leukemia

VAK694; Alutard Avanz SQ

Phase 2

Seasonal Allergic Rhinitis

BION-1301 Single Dose

Phase 2

IgA Nephropathy

QAW039 capsules once daily for 28 days

Phase 2

Persistent Asthma

Mycophenolic Acid

Phase 2

Kidney Transplantation

MenACWY-TT

Phase 2

Meningococcal Disease

RKI983A

Phase 2

Glaucoma

BKM120

Phase 2

PI3K Pathway Activated Tumors

Treosulfane

Phase 2

Prostate Cancer

hATG

Phase 2

Aplastic Anemia

QGE031

Phase 2

Allergic Asthma

Adjuvant endocrine therapy

Phase 2

Breast Cancer

JSB462

Phase 2

Prostatic Cancer, Castration-Resistant

LTP

Phase 2

Healthy Volunteers, Pulmonary Arterial Hypertension

ITU512

Phase 2

Sickle Cell Disease

BYM338 active drug

Phase 2

Cachexia

LDK378

Phase 2

Non-Small Cell Lung Cancer

Deferasirox dispersable tablet (DT)

Phase 2

Transfusion-dependent Thalassemia

Aliskiren 3.125 mini-tablets

Phase 2

Hypertension

Fluticasone 250 mcg

Phase 2

Asthma

75 µg indacaterol maleate (LB)

Phase 2

Asthma

KAF156

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Meningococcal B vaccine

Phase 2

Meningococcal Meningitis

68Ga-PSMA-11

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Influenza Vaccine, Formulation 2008-2009

Phase 2

Seasonal Influenza

rMenB

Phase 2

Meningococcal Disease

Pelacarsen (TQJ230) 80mg

Phase 2

Aortic Stenosis

MCS110

Phase 2

Pigmented Villonodular Synovitis

Omalizumab 75-375 mg

Phase 2

Chronic Urticaria

Three 1 mL doses of Rabies vaccine and two JE vaccine

Phase 2

Rabies

QAX028

Phase 2

Chronic Obstructive Pulmonary Disease

CGF166

Phase 2

Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss

MF59 adjuvanted H5N1 influenza vaccine

Phase 2

Influenza

EYU688

Phase 2

Dengue

DII235

Phase 2

Lipoprotein Disorder

LEZ763

Phase 2

Type II Diabetes

Indacaterol maleate 400 μg

Phase 2

Asthma

Secukinumab 10 mg/kg

Phase 2

Dry Eye

EGF816

Phase 2

Advanced Non-small Cell Lung Cancer

cyclosporine (reduced exposure) / everolimus

Phase 2

Kidney Transplantation

AEE788

Phase 2

Brain and Central Nervous System Tumors

MenACWY-CRM197

Phase 2

Meningococcal Disease

GIA632

Phase 2

Atopic Dermatitis

CPK850

Phase 2

Retinitis Pigmentosa

BAF312 solution

Phase 2

Hemorrhagic Stroke

Certoparin 3,000 IU Once Daily

Phase 2

Renal Insufficiency

QBW276

Phase 2

Pulmonary Cystic Fibrosis

short acting β2- agonist

Phase 2

COPD

valtorcitabine

Phase 2

Hepatitis B

LNA043

Phase 2

Osteoarthritis

LOU064 Arm 1

Phase 2

Chronic Spontaneous Urticaria

RAD001(everolimus)

Phase 2

Carcinoma

68Ga-FAP-2286

Phase 2

Solid Tumor

LFG316

Phase 2

Paroxysmal Nocturnal Hemoglobinuria

Sevelamer HCl

Phase 2

Chronic Kidney Disease

Seasonal Influenza Vaccine (MF59C.1)

Phase 2

Seasonal Influenza

MIJ821 Subcutaneous Injection 1 mg

Phase 2

Treatment-Resistant Depression

Dovitinib (TKI258)

Phase 2

Tumor Pathway Activations Inhibited by Dovitinib

sacubitril/valsartan (LCZ696)

Phase 2

Hypertension

NVA237 12.5 µg once daily

Phase 2

Chronic Obstructive Pulmonary Disease

Glucocorticoids

Phase 2

ANCA Associated Vasculitis (AAV)

Glycopyrronium bromide 25ug

Phase 2

Asthma

XXB750 drug

Phase 2

Resistant Hypertension

XBD173

Phase 2

Anxiety Disorders

INE963

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

CFZ533 - MMF - CS

Phase 2

Kidney Transplant Rejection

LCZ696A

Phase 2

Pharmacokinetics

alb-interferon alfa 2b

Phase 2

Chronic Hepatitis C

CFZ533

Phase 2

Lupus Nephritis

Panobinostat (LBH589)

Phase 2

Myelodysplastic Syndromes

Serelaxin

Phase 2

Labor, Induced

Rapcabtagene autoleucel

Phase 2

Idiopathic Inflammatory Myopathies

AMN107- NILOTINIB

Phase 2

Gastrointestinal Stromal Tumors (GIST)

Sumatriptan

Phase 2

Migraine

Oxybutynin

Phase 2

Healthy Volunteers

QAV680 + Cetirizine

Phase 2

Allergic Rhinitis

Influenza vaccine surface antigen adjuvanted with MF59

Phase 2

Pandemic Influenza Disease

RLX030 (serelaxin)

Phase 2

Chronic Heart Failure

Naproxen

Phase 2

Osteoarthritis

Tropifexor (LJN452)

Phase 2

Non-alcoholic Steatohepatitis (NASH)

zigakibart

Phase 2

Immunoglobulin A Nephropathy (IgAN)

VHB937

Phase 2

Amyotrophic Lateral Sclerosis (ALS)

Iscalimab

Phase 2

Sjogren's Syndrome

LXE408

Phase 2

Chagas Disease

Indacaterol 27.5 mcg

Phase 2

Asthma

SPP100

Phase 2

Hypertension

PTK787

Phase 2

Wet Age-Related Macular Degeneration

Enzalutamide

Phase 2

Advanced Solid Tumor

Prednisone

Phase 2

Lupus Nephritis

LBH589

Phase 2

Lymphoma

ACZ885 (investigational)

Phase 2

Rheumatoid Arthritis

CFZ533 active - Cohort 1

Phase 2

Primary Sjögren's Syndrome

ARV-766 Part A&B

Phase 2

Prostate Cancer Metastatic

Anastrozole

Phase 2

Breast Cancer

NGI226

Phase 2

Achilles Tendinopathy

AEB071

Phase 2

Uveitis

Core Study: Deferasirox

Phase 2

Transfusional Iron Overload

AQW051 2 mg (single and multiple doses)

Phase 2

Schizophrenia Disorders

serogroup B meningococcal vaccine

Phase 2

Meningococcal Disease

AIN457A

Phase 2

Ankylosing Spondylitis

Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy

Phase 2

Attention Deficit Hyperactivity Disorder

AFQ056

Phase 2

Parkinson's Disease

Patupilone

Phase 2

Metastatic Hormone Refractory Prostate Cancer

rapcabtagene autoleucel (YTB323)

Phase 2

Progressive Multiple Sclerosis

HSC835

Phase 2

Acute Myelocytic Leukemia

PDR001

Phase 2

Melanoma

QAX576

Phase 2

Asthma

Indacaterol 300μg

Phase 2

Chronic Obstructive Pulmonary Disease

LIK066

Phase 2

Elevated Body Mass Index

TKI258

Phase 2

Solid Tumors and Advanced Endometrial Cancer

QVM149 150/50/80 μg o.d.

Phase 2

Asthma

BHQ880

Phase 2

Smoldering Multiple Myeloma

DNK333

Phase 2

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Indacaterol (QAB149)

Phase 2

COPD

balicatib (AAE581)

Phase 2

Knee Osteoarthritis

Iptacopan (part 1)

Phase 2

Lupus Nephritis

MF59-eH5N1

Phase 2

Pandemic

UNR844-Cl

Phase 2

Presbyopia

Zoledronic Acid; Letrozole

Phase 2

Breast Cancer

epothilone b

Phase 2

Ovarian Neoplasms

PTK787/ZK 222584

Phase 2

Von Hippel-Lindau Disease

Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.

Phase 2

Invasive Meningococcal Disease

tisagenlecleucel

Phase 2

Follicular Lymphoma

Fluad H5N1 Pandemic Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza Vaccine

combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine

Phase 2

Meningococcal Infections

BEZ235 (Stage 1)

Phase 2

Pancreatic Neuroendocrine Tumors (pNET)

Meningococcal Vaccine

Phase 2

Meningococcal Disease

MenABCWY+OMV

Phase 2

Meningococcal Disease

AFQ056 with L-dopa

Phase 2

Parkinson's Disease

ICL670, deferoxamine

Phase 2

Anemia, Sickle Cell

IGE025

Phase 2

Chronic Idiopathic Urticaria

DFV890

Phase 2

Coronary Heart Disease

CMK389

Phase 2

Atopic Dermatitis

Nilotinib followed by treatment-free

Phase 2

Chronic Myelogenous Leukemia

[68Ga]Ga-NeoB

Phase 2

Breast Cancer

AUY922

Phase 2

Non-small-cell Lung Cancer

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

SBR759

Phase 2

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

STI571 (Glivec®)

Phase 2

Prostatic Neoplasm

MenC-CRM LIQ

Phase 2

Meningococcal Disease

LEE011

Phase 2

Teratoma

Simulect®

Phase 2

Renal Transplantation

NVGH Vi-CRM197

Phase 2

Typhoid Fever

MenACWY-CRM conjugate vaccine, adjuvanted

Phase 2

Prevention of Meningococcal Disease

VAK694

Phase 2

Allergic Rhinitis

BFH772 1% ointment

Phase 2

Erythemato-telangiectatic Rosacea

BGT226

Phase 2

Solid Tumors

Docetaxel

Phase 2

Advanced Gastric Cancer

Cyclosporine A

Phase 2

Atopic Dermatitis

Dexamethasone based mouthwash

Phase 2

Advanced Breast Cancer

SMC021

Phase 2

Health Postmenopausal Women

NVA237 100 µg

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

KAE609

Phase 2

Malaria

Vi-CRM197 vaccine

Phase 2

Typhoid Fever

Infliximab

Phase 2

Crohn's Disease

SAF312A

Phase 2

Postoperative Pain

indacaterol maleate / mometasone furoate

Phase 2

Asthma

Canakinumab (investigational)

Phase 2

Rheumatoid Arthritis

mometasone furoate

Phase 2

Asthma

GSK2118436

Phase 2

Cancer

Cipargamin

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

BZF961

Phase 2

Hepatitis C

Capmatinib

Phase 2

Carcinoma, Non-Small-Cell Lung

ABL001/Asciminib

Phase 2

Chronic Myeloid Leukemia (CML)

CLR325

Phase 2

Chronic Stable Heart Failure

H5N1 pandemic Influenza vaccine 3.75µg

Phase 2

Pandemic H5N1 Influenza

Dexamethasone

Phase 2

Immune Thrombocytopenia (ITP)

Evolocumab

Phase 2

Atherosclerotic Cardiovascular Disease

TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)

Phase 2

Parkinson's Disease

Rapcabtagene autoleucel single agent

Phase 2

Chronic Lymphocytic Leukemia

RFB002

Phase 2

Diabetic Macular Edema

[177Lu]Lu-DOTA-TATE

Phase 2

Extensive Stage Small Cell Lung Cancer

Indacaterol acetate

Phase 2

Asthma

MenACWY polysaccharide vaccine

Phase 2

Meningococcal Meningitis

Iloperidone crystalline formulation

Phase 2

Schizophrenia

CNP520

Phase 2

Alzheimer's Disease

Mometasone furoate/formoterol fumarate (MFF)

Phase 2

Asthma

LDE225

Phase 2

Basal Cell Carcinoma

BVS857

Phase 2

Spinal and Bulbar Muscular Atrophy

Montelukast

Phase 2

Asthma

LHW090

Phase 2

Patients, Resistant Hypertension

QMF149 Twisthaler®

Phase 2

Asthma

NIC002

Phase 2

Smokers

RAD001, Letrozole 2.5mg

Phase 2

Breast Neoplasm

LCI699

Phase 2

Hypertension

IV Artesunate

Phase 2

Severe Malaria

Aliskiren/ Valsartan

Phase 2

Hypertension

MAS825

Phase 2

COVID-19 Pneumonia, Impaired Respiratory Function

QBW251

Phase 2

Pulmonary Disease, Chronic Obstructive

BYM338

Phase 2

Skeletal Muscle

DNK333 100 mg twice daily

Phase 2

Chronic Obstructive Pulmonary Disease

ECF843

Phase 2

Dry Eye

LBH589 (panobinostat)

Phase 2

Relapse/Refractory Multiple Myeloma

LFF571

Phase 2

Moderate Clostridium Difficile Infection

LLG783

Phase 2

Peripheral Artery Disease (PAD); Intermittent Claudication

KRP203 - 1.2mg

Phase 2

Subacute Cutaneous Lupus Erythematosus

Panobinostat/LBH589

Phase 2

Refractory Leukemia

Fenofibrate

Phase 2

Non Familial Chylocmicronemia Syndrome (Non-FCS)

Seasonal flu vaccine

Phase 2

Seasonal Influenza

STI571 400 mg

Phase 2

Philadelphia Positive Chronic Myeloid Leukemia

bortezomib

Phase 2

Multiple Myeloma

AIN 457

Phase 2

Non-infectious Uveitis

CJM112

Phase 2

Hidradenitis Suppurativa (Acne Inversa)

Entacapone

Phase 2

Parkinson's Disease

STI571

Phase 2

Systemic Sclerosis, Scleroderma

Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07

Phase 2

Influenza

H5N1 Influenza Vaccine

Phase 2

Prophylaxis of Avian Influenza

VAY736 1ml PFS

Phase 2

Sjögrens Disease

DTaP-Hib-IPV

Phase 2

Meningococcal Disease

AHU377

Phase 2

Hypertension

Investigational new drug, company code: BGG492

Phase 2

Partial Onset Seizures

INC280

Phase 2

Non-small Cell Lung Cancer

Deferasirox granule formulation

Phase 2

Transfusion-dependent Anemia

Deferasirox dispersible tablet

Phase 2

Chronic Iron Overload Due to Transfusion-dependant Anemias

Daunorubicin

Phase 2

Acute Leukaemia

AMO959

Phase 2

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg

Phase 2

Heartburn

Group B Streptococcus Trivalent Vaccine

Phase 2

Streptococcal Infection

MenACWY-CRM Vaccine

Phase 2

Prevention of Meningococcal Disease

Influenza Trivalent Inactivated Vaccines

Phase 2

FLU

Asciminib Pediatric formulation group

Phase 2

Myeloid Leukemia, Philadelphia Positive

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine

Phase 2

Meningococcal Disease

MenABCWY

Phase 2

Meningococcal Disease

Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009

Phase 2

Influenza

BGG492

Phase 2

Photosensitive Epilepsy

Group B streptococcus vaccine

Phase 2

Streptococcal Infections

Novartis Meningococcal (MenACWY-CRM) vaccine

Phase 2

Meningococcal Disease

MenC-CRM

Phase 2

Meningococcal Meningitis

MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation)

Phase 2

Prevention of Meningococcal Disease

SOM230 s.c.

Phase 2

Cushing's Syndrome

Panitumumab

Phase 2

Cancer

Abiraterone

Phase 2

Metastatic Hormone-sensitive Prostate Cancer

Indacaterol acetate 75 μg

Phase 2

Asthma

Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)

Phase 2

Human Influenza

Buparlisib

Phase 2

Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Eplerenone

Phase 2

Essential Hypertension

Everolimus 10 mg

Phase 2

Islet Cell Carcinoma

Bridging Therapy

Phase 2

Non-Hodgkin Lymphoma

Nazartinib

Phase 2

Advanced Solid Tumors Which Are cMET-dependent

LRX712

Phase 2

Osteoarthritis (OA)

LAG525

Phase 2

Triple-negative Breast Cancer

Deferasirox DFX, DT

Phase 2

Low and Int 1-risk Myelodysplastic Syndrome

DTIC

Phase 2

Melanoma

Rabbit ATG

Phase 2

Aplastic Anemia

CSJ148

Phase 2

HCMV

SAF312

Phase 2

Postoperative Ocular Pain After PRK Surgery

Imatinib 600mg/day (Glevec is the brand name for imatinib)

Phase 2

Gastrointestinal Stromal Tumors

Votoplam

Phase 2

Huntington Disease

Surface antigen inactivated influenza vaccine

Phase 2

Influenza

Tulmimetostat

Phase 2

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

PTK787/ZK 222584 (vatalanib)

Phase 2

Tumors

Aliskiren 150 mg

Phase 2

Heart Failure

CAD106

Phase 2

Alzheimer Disease

LXH254

Phase 2

Melanoma

GVV858

Phase 2

Advanced HR+/HER2- Breast Cancer

AAE581

Phase 2

Osteoporosis

Trivalent subunit inactivated flu vaccine, Formulation 2010-2011

Phase 2

Seasonal Influenza

Pandemic influenza vaccine + seasonal influenza vaccine /pandemic influenza vaccine

Phase 2

Influenza

AUY922 2 mg/m2

Phase 2

Breast Cancer

aTIV

Phase 2

Human Influenza

Group B Streptococcus Trivalent Vaccine - 20/20/20 μg

Phase 2

Streptococcal Infections

LCQ908A

Phase 2

Type 2 Diabetes Mellitus

CTL019 T-cells

Phase 2

B-cell Acute Lymphoblastic Leukemia

Deferasirox (ICL670)

Phase 2

Chronic Anemia

MF59C.1-adjuvanted subunit influenza vaccine

Phase 2

Seasonal Influenza

NSAI: Letrozole or Anastrazole

Phase 2

Breast Cancer

Investigational Treatment

Phase 2

External Genital Warts

rabbit anti-thymocyte globulin (r-ATG)

Phase 2

Severe Aplastic Anemia (SAA)

Men ACWY CRM

Phase 2

Meningococcal Disease

GXV813

Phase 2

Schizophrenia

Methotrexate

Phase 2

Rheumatoid Arthritis

DYP688

Phase 2

Metastatic Uveal Melanoma

LJN452

Phase 2

Primary Bile Acid Diarrhea

FGF401

Phase 2

Hepatocellular Carcinoma (HCC)

Asciminib add-on

Phase 2

CML

Indacaterol 150 μg via the Concept1 dry-powder inhaler

Phase 2

Asthma

Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008

Phase 2

Influenza

Ranibizumab 0.3 mg

Phase 2

Diabetic Macular Edema

SOM230

Phase 2

Dumping Syndrome

Secukinmab

Phase 2

Rheumatoid Arthritis

225Ac-PSMA-R2

Phase 2

Prostate Cancer

Alum

Phase 2

Alzheimer's Disease

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Anecortave Acetate Sterile Suspension, 30 mg/mL

Phase 2

Open-angle Glaucoma

Letrozole OR Anastrozole

Phase 2

Breast Cancer

Nepafenac Ophthalmic Suspension, 0.3%

Phase 2

Cataract

KAE609 (Cipargamin)

Phase 2

Uncomplicated Plasmodium Falciparum Malaria

Difluprednate 0.05% ophthalmic emulsion

Phase 2

Dry Eye Disease

anecortave acetate

Phase 2

AMD

RHH646

Phase 2

Osteoarthritis, Knee

carboplatin

Phase 2

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

ARPI: Abiraterone

Phase 2

Metastatic Castration Resistant Prostate Cancer (mCRPC)

high-dose imatinib

Phase 2

CML

indacaterol/glycopyrrolate

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

BFH772

Phase 2

Psoriasis

ECI830

Phase 2

Advanced HR+/HER2- Breast Cancer

Atrasentan

Phase 2

IgA Nephropathy

Influenza Trivalent Inactivated vaccines Novartis

Phase 2

Influenza

Lapatinib/nab-Paclitaxel

Phase 2

Neoplasms, Breast

Lymphodepleting chemotherapy

Phase 2

Diffuse Large B-cell Lymphoma (DLBCL)

TIN816 70 mg lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

APL180

Phase 2

Coronary Heart Disease

CSJ117

Phase 2

Pulmonary Disease, Chronic Obstructive

Deferasirox and Deferoxamine

Phase 2

Cardiac Iron Overload

NIM811

Phase 2

Chronic Hepatitis C Genotype-1 Relapse

BYL719

Phase 2

Breast Cancer

Coartem

Phase 2

Acute Uncomplicated Plasmodium Falciparum Malaria

Colchicine

Phase 2

Gout

LKA651

Phase 2

Diabetic Macular Edema

Terlipressin acetate

Phase 2

Compensated Cirrhosis and Portal Hypertension

Prednisolone

Phase 2

Giant Cell Arteritis

RAF265

Phase 2

Metastatic Melanoma

Aggripal®

Phase 2

Human Influenza

AQW051

Phase 2

Dyskinesias

Drug Name	Phase	Indication	Designations	Patent
Octreotide Acetate in Microspheres 20 mg	Phase 3	Diabetic Retinopathy	-	-
Olaparib	Phase 3	Ovarian Cancer	-	-
Verteporfin photodynamic therapy	Phase 3	Macular Degeneration	-	-
Glycopyrronium bromide	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
LOU064 25 mg (b.i.d)	Phase 3	Chronic Spontaneous Urticaria	-	-
Vemurafenib	Phase 3	Melanoma	-	-
INC424	Phase 3	Myelofibrosis	-	-
Fluvastatin	Phase 3	Heterozygous Familial Hypercholesterolemia	-	-
Tobramycin Solution for Inhalation	Phase 3	Cystic Fibrosis	-	-
indacaterol and glycopyrronium (QVA149)	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Ranibizumab 0.5mg	Phase 3	Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)	-	-
Certican	Phase 3	Kidney Transplantation	-	-
Zoledronic acid 5 mg iv	Phase 3	Male Osteoporosis	-	-
fluvastatin, ezetimibe	Phase 3	Dyslipidemia	-	-
Artemether-lumefantrine (COA566)	Phase 3	Acute Uncomplicated Falciparum Malaria	-	-
Pasireotide LAR	Phase 3	Acromegaly	-	-
Rivastigmine capsule	Phase 3	Parkinson's Disease Dementia	-	-
Sham ranibizumab	Phase 3	Diabetic Macular Edema	-	-
Enteric-coated Mycophenolate Sodium	Phase 3	Autoimmune Disease	-	-
pioglitazone	Phase 3	Diabetes Mellitus, Type 2	-	-
valsartan + amlodipine	Phase 3	Hypertension	-	-
Indacaterol acetate/Mometasone furoate	Phase 3	Asthma	-	-
oxcarbazepine	Phase 3	Epilepsy	-	-
Trametinib	Phase 3	Cancer	-	-
glycopyrronium (NVA237)	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
panobinostat	Phase 3	Relapsed and Bortezomib Refractory Multiple Myeloma	-	-
CTL019	Phase 3	B-cell Acute Lymphoblastic Leukemia	-	-
Rivastigmine 5 cm^2 transdermal patch	Phase 3	Alzheimer's Disease	-	-
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets	Phase 3	Upper Respiratory Tract Infection	-	-
Diclofenac sodium topical gel 1%	Phase 3	Ankle Sprain	-	-
interferon-alpha (INF-a)	Phase 3	Chronic Myelogenous Leukemia	-	-
QMF149 150/80 μg	Phase 3	Mild Asthma	-	-
Rivastigmine	Phase 3	Vascular Dementia	-	-
RLX030	Phase 3	Chronic Heart Failure (CHF)	-	-
Valsartan 160 mg capsules	Phase 3	Essential Hypertension	-	-
Secukinumab (AIN457)	Phase 3	Psoriatic Arthritis	-	-
Remibrutinib Dose A	Phase 3	Hidradenitis Suppurativa	-	-
HCQ	Phase 3	Covid-19	-	-
Omalizumab	Phase 3	Asthma	-	-
Tegaserod	Phase 3	Heartburn	-	-
valsartan 160 mg	Phase 3	Chronic Heart Failure	-	-
letrozole	Phase 3	Breast Cancer	-	-
Minimisation of TAC	Phase 3	Liver Transplant	-	-
Haemophilus influenzae type b (Hib) vaccine	Phase 3	Haemophilus Influenzae Type b (Hib) Infection	-	-
Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine	Phase 3	Meningococcal Meningitis	-	-
ICL670	Phase 3	Transfusional Iron Overload	-	-
sunitinib	Phase 3	Renal Cell Carcinoma	-	-
Amlodipine	Phase 3	Essential Hypertension	-	-
MenACWY-CRM + MMRV	Phase 3	Meningococcal Infections	-	-
Indacaterol 150 µg	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
QIVc	Phase 3	Influenza	-	-
Lumiracoxib	Phase 3	Osteoarthritis	-	-
LCZ	Phase 3	Hypertension	-	-
Abatacept	Phase 3	Rheumatoid Arthritis	-	-
eH1N1_f	Phase 3	Novel 2009 Influenza H1N1	-	-
Monovalent glyco-conjugated vaccine against Haemophilus influenzae type b (Hib)	Phase 3	Haemophilus Influenzae Type b (Hib) Infection	-	-
Valsartan/amlodipine 160/5 mg	Phase 3	Essential Hypertension	-	-
Cell culture derived seasonal trivalent influenza vaccine (cTIV)	Phase 3	Influenza	-	-
Monovalent inactivated influenza vaccine	Phase 3	Pre-pandemic Influenza Vaccine	-	-
Eltrombopag Tablets	Phase 3	Purpura, Thrombocytopenic, Idiopathic	-	-
amlodipine/benazepril	Phase 3	Hypertension	-	-
cTIV	Phase 3	Seasonal Influenza Vaccine	-	-
etanercept	Phase 3	Chronic Plaque Psoriasis	-	-
lisinopril	Phase 3	Hypertension	-	-
TQJ230	Phase 3	Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease	-	-
Dexmethylphenidate HCl extended-release capsules	Phase 3	ADHD, ADD	-	-
Trivalent split influenza vaccine (TIV)	Phase 3	Influenza Disease	-	-
preservative free inactivated split influenza vaccine using the strain composition 2006/2007	Phase 3	Influenza	-	-
LCZ696	Phase 3	Heart Failure	-	-
Ribociclib	Phase 3	Early Breast Cancer	-	-
Pelabresib	Phase 3	Hematologic Malignancy	-	-
Amlodipine 5 mg	Phase 3	Hypertension	-	-
Ranibizumab 0.5 mg	Phase 3	Macular Edema Secondary to Branch Retinal Vein Occlusion	-	-
Mycophenolate sodium	Phase 3	Kidney Transplantation	-	-
Valsartan 0.25 mg/kg	Phase 3	Hypertension	-	-
rMenB+OMV NZ	Phase 3	Meningococcal Disease	-	-
Triamcinolone acetonide 40 mg	Phase 3	Acute Gouty Arthritis Flares	-	-
TIVc	Phase 3	Human Influenza	-	-
Chemotherapy	Phase 3	Acute Myeloid Leukemia (AML)	-	-
Rabies vaccines + Rabies immunoglobulins	Phase 3	Rabies Infection	-	-
Canakinumab (AIN457)	Phase 3	Periodic Fevers Syndrome	-	-
Meningococcal ACWY conjugate vaccine (MenACWY-CRM)	Phase 3	Meningococcal Disease	-	-
onasemnogene abeparvovec-xioi	Phase 3	Spinal Muscular Atrophy	-	-
No Vaccine	Phase 3	Meningococcal Disease	-	-
Gliclazide	Phase 3	Diabetes Mellitus, Type 2	-	-
Dabrafenib	Phase 3	Melanoma	-	-
Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011	Phase 3	Seasonal Influenza	-	-
Novartis MenACWY-CRM	Phase 3	Meningococcal Disease	-	-
Rivastigmine Transdermal Patch	Phase 3	Alzheimer's Disease	-	-
Ligelizumab	Phase 3	Chronic Spontaneous Urticaria	-	-
EPO906 (Patupilone)	Phase 3	Ovarian Cancer	-	-
Zagreb	Phase 3	Rabies	-	-
Best Available Therapy (BAT)	Phase 3	Myelofibrosis	-	-
Metformin Comparator	Phase 3	Diabetes Mellitus, Type 2	-	-
Ritalin LA 20 mg	Phase 3	Attention Deficit/Hyperactivity Disorder	-	-
valsartan/amlodipine	Phase 3	Hypertension	-	-
Haemophilus influenzae type b vaccine	Phase 3	Haemophilus Influenzae Type b	-	-
Pazopanib	Phase 3	Solid Tumours	-	-
Lot A of Influenza virus vaccine	Phase 3	Influenza	-	-
Aliskiren (6.25/12.5/25 mg)	Phase 3	Hypertension	-	-
Routine Vaccines	Phase 3	Meningococcal Disease	-	-
LOU064	Phase 3	Chronic Spontaneous Urticaria	-	-
QMF149	Phase 3	Asthma	-	-
FTY 720	Phase 3	Kidney Transplantation	-	-
Midostaurin	Phase 3	FLT3-mutated Acute Myeloid Leukemia	-	-
Ofatumumab subcutaneous injection	Phase 3	Relapsing Multiple Sclerosis	-	-
Enteric-coated mycophenolate sodium (EC-MPS)	Phase 3	Renal Transplantation	-	-
Lamivudine	Phase 3	Hepatitis	-	-
DTwP-HepB-Hib Vaccine	Phase 3	Diphtheria	-	-
TIVf	Phase 3	Human Influenza	-	-
Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine	Phase 3	Influenza	-	-
AAA817	Phase 3	Prostate Cancer	-	-
Indacaterol 150 μg capsules	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Hib-CRM197	Phase 3	Meningitis, Epiglottitis, Pneumonia, Arthritis Caused by Haemophilus Influenzae Type b	-	-
Investigators choice of SoC	Phase 3	Prostate Cancer	-	-
Valsartan/hydrochlorothiazide (HCTZ)	Phase 3	Hypertension	-	-
QVM149 150/50/160	Phase 3	Asthma	-	-
LNP023	Phase 3	IgA Nephropathy	-	-
Verteporfin PDT	Phase 3	Pathological Myopia	-	-
AMG334 (70 mg) Pre-Filled Syringe (PFS)	Phase 3	Episodic Migraine	-	-
Valsartan + amlodipine 40/2.5 mg	Phase 3	Essential Hypertension	-	-
177Lu-PSMA-617	Phase 3	Prostatic Neoplasms	-	-
Ali/Amlo 150/2.5 mg	Phase 3	Essential Hypertension	-	-
AIN457 (secukinumab)	Phase 3	Psoriatic Arthritis	-	-
Ezetimibe	Phase 3	Hypercholesterolemia	-	-
Trivalent influenza virus vaccine (TIV)	Phase 3	Pandemic Influenza Disease	-	-
Inclisiran Sodium	Phase 3	ASCVD	-	-
Introduction of everolimus with reduced cyclosporine or tacrolimus dose, the earliest 1 month and the latest 6 months after liver transplantation.	Phase 3	Renal Function	-	-
Ruxolitinib	Phase 3	Primary Myelofibrosis (MF)	-	-
Dupilumab	Phase 3	Chronic Spontaneous Urticaria (CSU)	-	-
Tiotropium	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Lapatinib	Phase 3	Neoplasms, Breast	-	-
Remibrutinib (Open Label)	Phase 3	Generalized Myasthenia Gravis	-	-
Aliskiren/HCTZ	Phase 3	Hypertension	-	-
Fumaric acid	Phase 3	Psoriasis	-	-
Hydrochlorothiazide (HCTZ)	Phase 3	Hypertension	-	-
Ustekinumab	Phase 3	Plaque Psoriasis	-	-
Inclisiran sodium 300 mg	Phase 3	Coronary Artery Disease	-	-
MenACWY-CRM	Phase 3	Meningococcal Infections	-	-
eltrombopag olamine (SB-497115-GR)	Phase 3	Purpura, Thrombocytopaenic, Idiopathic	-	-
Secukinumab 300mg	Phase 3	Palmoplantar Pustular Psoriasis	-	-
Methylphenidate hydrochloride	Phase 3	ADHD	-	-
diclofenac diethylamine gel 2.32%	Phase 3	Grade I/II Ankle Sprain	-	-
Imatinib mesilate	Phase 3	Refractory Desmoplastic Small Round Cell Tumors	-	-
Canakinumab 150mg in prefilled syringe	Phase 3	Acute Gouty Arthritis	-	-
Agomelatine (AGO178C)	Phase 3	Major Depressive Disorder	-	-
QAW039	Phase 3	Asthma	-	-
Iptacopan	Phase 3	Glomerulonephritis, IGA	-	-
Unfractionated Heparin	Phase 3	Thromboembolism	-	-
Cisplatin	Phase 3	Non-Small Cell Lung Cancer	-	-
Secukinumab 150 mg provided in 1.0 mL pre-filled syringes (PFSs) for sc injection.	Phase 3	Ankylosing Spondylitis	-	-
Cell culture-derived influenza subunit vaccine (cTIV)	Phase 3	Influenza	-	-
LCZ696 (sacubitril/valsartan)	Phase 3	Acute Myocardial Infarction	-	-
Secukinumab 300 mg, s.c.	Phase 3	Giant Cell Arteritis	-	-
Entecavir	Phase 3	Hepatitis B	-	-
Adjuvanted influenza vaccine	Phase 3	Influenza Disease	-	-
Certoparin	Phase 3	Persistent Nonvalvular Atrial Fibrillation	-	-
Meningococcal ACWY-CRM conjugate vaccine	Phase 3	Meningococcal Disease	-	-
BEGRIVAC	Phase 3	Seasonal Influenza	-	-
Cell culture derived influenza vaccine	Phase 3	Influenza	-	-
Salmeterol 50 μg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Olmesartan	Phase 3	Essential Hypertension	-	-
Rabies	Phase 3	Rabies	-	-
1a - rMenB+OMV NZ and routine vaccines	Phase 3	Meningococcal Disease	-	-
formoterol	Phase 3	Asthma	-	-
Influenza Virus Vaccine	Phase 3	Influenza Disease; Flu	-	-
Fingolimod	Phase 3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy	-	-
capecitabine	Phase 3	Metastases, Brain	-	-
Adjuvanted seasonal influenza vaccine	Phase 3	Influenza	-	-
Aliskiren 150 mg tablet	Phase 3	Hypertension	-	-
Pasireotide sub-cutaneous	Phase 3	Cushing's Disease	-	-
Alpelisib	Phase 3	Advanced Breast Cancer	-	-
RAD001	Phase 3	Metastatic Renal Cell Carcinoma	-	-
Experimental : Secukinumab low dose	Phase 3	Chronic Severe Plaque-type Psoriasis	-	-
Trivalent influenza virus vaccine (TIVf)	Phase 3	Human	-	-
Ceritinib	Phase 3	ALK-positive Non-small Cell Lung Cancer	-	-
vinorelbine	Phase 3	HER2/Neu Over-expressing Locally Advanced Breast Cancer	-	-
Hydrochlorothiazide	Phase 3	Hypertension	-	-
AMN107	Phase 3	Gastrointestinal Stromal Tumors	-	-
Terbinafine	Phase 3	Tinea Pedis	-	-
CDZ173	Phase 3	Common Variable Immunodeficiency (CVID), APDS / PASLI	-	-
Everolimus (RAD001)	Phase 3	Tuberous Sclerosis Complex (TSC)	-	-
tacrolimus	Phase 3	Liver Transplantation	-	-
Ramipril	Phase 3	Hypertension	-	-
Monovalent A/H1N1 influenza vaccine	Phase 3	Pandemic Influenza	-	-
Valsartan + Hydrochlorothiazide	Phase 3	Hypertension	-	-
Terbinafine hydrochloride (HCl)	Phase 3	Tinea Capitis	-	-
dovitinib	Phase 3	Hepatocellular Carcinoma	-	-
Aliskiren 150/300 mg	Phase 3	Hypertension	-	-
Bimagrumab	Phase 3	Sporadic Inclusion Body Myositis	-	-
Remibrutinib (blinded)	Phase 3	Secondary Progressive Multiple Sclerosis (SPMS)	-	-
MenACWY-CRM197 (two doses)	Phase 3	Meningococcal Meningitis	-	-
Meningococcal C conjugate vaccine	Phase 3	Prevention of Meningococcal Infection	-	-
Cell culture-derived trivalent subunit influenza vaccine (cTIV)	Phase 3	Influenza	-	-
Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ	Phase 3	Essential Hypertension	-	-
Iptacopan (LNP023)	Phase 3	Paroxysmal Nocturnal Hemoglobinuria (PNH)	-	-
Mycophenolate sodium (enteric coated)	Phase 3	Renal Transplant	-	-
Diclofenac potassium	Phase 3	Post Operative Dental Pain	-	-
valsartan+amlodipine	Phase 3	Hypertension	-	-
MenACWY-CRM conjugate vaccine	Phase 3	Meningococcal Meningitis	-	-
canakinumab (company code: ACZ885D)	Phase 3	Cryopyrin Associated Periodic Syndrome	-	-
Siponimod	Phase 3	Multiple Sclerosis	-	-
Background lipid lowering therapy	Phase 3	Atherosclerotic Cardiovascular Disease	-	-
Everolimus + Cyclosporine	Phase 3	Renal Transplantation	-	-
Darifenacin	Phase 3	Overactive Bladder Syndrome	-	-
Umeclidinium/vilanterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Zoledronic acid 4 mg	Phase 3	Non-Small-Cell Lung Cancer	-	-
Salmeterol 50 µg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Indacaterol 300 μg	Phase 3	Asthma	-	-
TOBI	Phase 3	Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients	-	-
telbivudine or lamivudine	Phase 3	Chronic Hepatitis B	-	-
Vildagliptin 50 mg bid	Phase 3	Type 2 Diabetes Mellitus	-	-
QVM149	Phase 3	Asthma	-	-
rMenB+OMV NZ with routine vaccinations	Phase 3	Meningococcal Disease	-	-
Aromatase Inhibitor	Phase 3	Neoplasms, Breast	-	-
Sham to ranibizumab	Phase 3	Diabetic Macular Edema	-	-
Cell culture-derived influenza vaccine	Phase 3	Influenza	-	-
Typhoid Vi Polysaccharide Vaccine	Phase 3	Meningococcal Disease	-	-
vildagliptin + metformin	Phase 3	Diabetes Mellitus, Type 2	-	-
Licarbazepine	Phase 3	Bipolar I Disorder	-	-
NVA237 50µg once daily	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Adjuvanted trivalent inactivated subunit influenza vaccine	Phase 3	Influenza, Human	-	-
Secukinumab 2 mL form	Phase 3	Psoriasis	-	-
Aflibercept 2 mg	Phase 3	Neovascular Age-related Macular Degeneration	-	-
Osilodrostat	Phase 3	Cushing's Syndrome	-	-
Everolimus 0.25 and 0.75 mg tablets	Phase 3	Transplantation Infection	-	-
Amlodipine 10 mg	Phase 3	Hypertension	-	-
sitagliptin	Phase 3	Diabetes Mellitus, Type 2	-	-
Secukinumab 2 mL auto-injector	Phase 3	Plaque Psoriasis	-	-
BAF312	Phase 3	Secondary Progressive Multiple Sclerosis	-	-
ABL001 40mg BID	Phase 3	Chronic Myelogenous Leukemia	-	-
VAY736	Phase 3	Primary Sjogren Syndrome	-	-
Terbinafine hydrochloride	Phase 3	Tinea Capitis	-	-
Cyclosporine (Neoral)	Phase 3	Organ Transplantation, Renal Transplantation	-	-
Methylphenidate 20 mg long-acting capsules	Phase 3	Attention Deficit Hyperactivity Disorder	-	-
Inclisiran Sodium for injection	Phase 3	Homozygous Familial Hypercholesterolemia	-	-
paroxetine	Phase 3	Major Depressive Disorder	-	-
salbutamol/albuterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Aliskiren	Phase 3	Hypertension	-	-
Ianalumab (VAY736)	Phase 3	Sjogrens Syndrome	-	-
Myfortic	Phase 3	Kidney Transplantation	-	-
Pelacarsen (TQJ230)	Phase 3	Atherosclerotic Cardiovascular Disease	-	-
Secukinumab	Phase 3	Psoriatic Arthritis	-	-
Next Generation Ophthalmic Irrigating Solution (NGOIS)	Phase 3	Eye Diseases	-	-
AIN457	Phase 3	Behcet Disease	-	-
Alcon Investigational Agent	Phase 3	Open-Angle Glaucoma	-	-
rMenB+OMV	Phase 3	Healthy	-	-
Vatalanib	Phase 3	Colorectal Neoplasms	-	-
Fluticasone	Phase 3	Asthma	-	-
Aflibercept	Phase 3	Diabetic Macular Edema	-	-
Rivastigmine Patch	Phase 3	Alzheimer's Disease	-	-
Abbreviated Zagreb 2-1-1 schedule	Phase 3	Rabies	-	-
Everolimus	Phase 3	Kidney Transplantation	-	-
mycophenolate mofetil	Phase 3	Graft Rejection	-	-
Travoprost 0.004%/Timolol 0.5% BAC-free ophthalmic solution	Phase 3	Open-Angle Glaucoma	-	-
QAB149	Phase 3	COPD	-	-
AL-4943A ophthalmic solution	Phase 3	Allergic Conjunctivitis	-	-
Nepafenac Ophthalmic Suspension, 0.1%	Phase 3	Cataract	-	-
Fulvestrant	Phase 3	Breast Cancer	-	-
AAA617	Phase 3	Oligometastatic Prostate Cancer (OMPC)	-	-
Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension	Phase 3	Open-Angle Glaucoma	-	-
0.003% AR-15512 ophthalmic solution	Phase 3	Dry Eye Disease	-	-
Valsartan 160 mg + nateglinide 60 mg	Phase 3	Diabetes Mellitus, Type 2	-	-
valsartan + simvastatin	Phase 3	HYPERTENSION	-	-
[18F]CTT1057	Phase 3	Prostatic Neoplasms	-	-
ranibizumab	Phase 3	Choroidal Neovascularization	-	-
Ranibizumab 0.3 mg - 3 times monthly, then quarterly	Phase 3	Age Related Macular Degeneration	-	-
TIV1c	Phase 3	Influenza	-	-
NVA237	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
NVA237 (glycopyrronium bromide)	Phase 3	Asthma	-	-
Erenumab	Phase 3	Migraine	-	-
imatinib mesylate	Phase 3	Leukemia	-	-
Diclofenac sodium	Phase 3	Acute Blunt Soft Tissue Injuries/Contusions	-	-
Teriflunomide capsule	Phase 3	Relapsing Multiple Scelrosis	-	-
Long-acting beta2-agonist	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Hydroxyurea	Phase 3	Glioblastoma Multiforme	-	-
Lapatinib (GW572016) oral tablets	Phase 3	Neoplasms, Breast	-	-
QTI571	Phase 3	Severe Pulmonary Arterial Hypertension	-	-
BYM338 (Bimagrumab)	Phase 3	Sporadic Inclusion Body Myositis (sIBM)	-	-
oral adefovir	Phase 3	Hepatitis B, Chronic	-	-
Oxaliplatin	Phase 3	Neoplasms, Gastrointestinal Tract	-	-
diclofenac diethylamine, DDEA 2.32% gel	Phase 3	Osteoarthritis, Knee	-	-
Relaxin	Phase 3	Heart Failure, Congestive	-	-
Novartis Meningococcal ACWY Conjugate Vaccine	Phase 3	Meningococcal Meningitis	-	-
Secukinumab/Adalimumab-Biosimilar	Phase 3	Axial Spondyloarthritis	-	-
Atenolol	Phase 3	Hypertension	-	-
Valsartan	Phase 3	Hypertension	-	-
Meningococcal (group B) multicomponent recombinant adsorbed vaccine	Phase 3	Meningitis, Meningococcal, Serogroup B	-	-
cyclosporine	Phase 3	de Novo Kidney Transplant Recipients	-	-
Octreotide LAR	Phase 3	Somatostatin Receptor Positive (SSTR+)	-	-
Clozapine	Phase 3	Schizophrenia	-	-
indacaterol maleate	Phase 3	Asthma	-	-
Zoledronic acid	Phase 3	Cancer Prostate	-	-
Glimepiride	Phase 3	Diabetes Mellitus, Type 2	-	-
Valsartan/amlodipine 80/5 mg	Phase 3	Hypertension	-	-
secukinumab 150 mg	Phase 3	Moderate to Severe Plaque-type Psoriasis	-	-
Diclofenac Topical Sodium Gel 1%	Phase 3	Osteoarthritis	-	-
Pasireotide	Phase 3	Cushing Disease	-	-
QVA149	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Antiepileptic drug (1 to 3 only)	Phase 3	Tuberous Sclerosis Complex-associated Refractory Seizures	-	-
Aliskiren/hydrochlorothiazide (HCTZ) (300/25 mg)	Phase 3	Hypertension	-	-
ianalumab s.c. q4w	Phase 3	Lupus Nephritis	-	-
Crizanlizumab	Phase 3	Sickle Cell Disease	-	-
Best Available Therapy	Phase 3	Polycythemia Vera	-	-
Bexsero® vaccine (1 dose at study month zero)	Phase 3	Meningoccocal Disease	-	-
Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)	Phase 3	N. Meningitidis Carriage	-	-
basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent)	Phase 3	Pediatric Kidney Transplantation	-	-
Valsartan + HCTZ	Phase 3	Hypertension	-	-
deferoxamine	Phase 3	Beta-Thalassemia	-	-
Valsartan and simvastatin	Phase 3	Hypertension	-	-
Pelacarsen (TQJ230) 80 mg s.c.	Phase 3	Hyperlipoproteinemia(a)	-	-
AIN457 150mg	Phase 3	Moderate to Severe Plaque-type Psoriasis	-	-
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL	Phase 3	Primary Prevention of Atherosclerotic Cardiovascular Disease	-	-
secukinumab 300 mg	Phase 3	Moderate to Severe Palmoplantar Psoriasis	-	-
[68Ga]Ga-DOTA-TATE	Phase 3	Neuroendocrine Neoplasms	-	-
Pemetrexed	Phase 3	Non-Small Cell Lung Cancer	-	-
asciminib	Phase 3	Leukemia, Chronic Myelogenous	-	-
DTaP-IPV-HBV	Phase 3	Meningitis, Meningococcal	-	-
Fingolimod 1.25 mg	Phase 3	Relapsing-remitting Multiple Sclerosis	-	-
Benazepril plus hydrochlorothiazide	Phase 3	Hypertension	-	-
Paclitaxel	Phase 3	Breast Cancer	-	-
LOU064 (blinded)	Phase 3	Chronic Spontaneous Urticaria	-	-
LCQ908	Phase 3	Non-alcoholic Fatty Liver Disease (NAFLD)	-	-
Everolimus (Certican)	Phase 3	Heart Transplantation	-	-
Cell-Derived Trivalent Subunit Influenza Vaccine Lot 1 (cTIV)	Phase 3	Influenza	-	-
Focalin XR	Phase 3	ADHD	-	-
Brolucizumab	Phase 3	Diabetic Macular Edema	-	-
BYM338/bimagrumab	Phase 3	Sporadic Inclusion Body Myositis	-	-
Taxotere	Phase 3	Non Small Cell Lung Carcinoma	-	-
Vildagliptin	Phase 3	Diabetes Mellitus, Type 2	-	-
AIN457 300 mg	Phase 3	Chronic Plaque Type Psoriasis	-	-
MF59-eH1N1_f	Phase 3	Influenza	-	-
Sildenafil	Phase 3	Mild to Moderate Hypertension	-	-
KLU156	Phase 3	Uncomplicated Plasmodium Falciparum Malaria	-	-
DTaP-IPV/Hib	Phase 3	Meningococcal Disease	-	-
thiazolidinedione (TZD)	Phase 3	Diabetes Mellitus, Type 2	-	-
Vildagliptin 100 mg qd	Phase 3	Diabetes Mellitus, Type 2	-	-
Metformin	Phase 3	Diabetes Mellitus, Type 2	-	-
tobramycin	Phase 3	Pseudomonas Infections	-	-
Ianalumab	Phase 3	Warm Autoimmune Hemolytic Anemia (wAIHA)	-	-
inactivated split influenza vaccine	Phase 3	Seasonal Influenza	-	-
Artemether-lumefantrine	Phase 3	Malaria	-	-
Brolucizumab 6 mg	Phase 3	Proliferative Diabetic Retinopathy	-	-
FTY720	Phase 3	Renal Transplantation	-	-
LOU064 (open label)	Phase 3	Chronic Spontaneous Urticaria	-	-
Dexamethasone implant and sham injections	Phase 3	Visual Impairment	-	-
Mammalian cell based flu vaccine	Phase 3	Influenza	-	-
secukinumab 150mg	Phase 3	Plaque-type Psoriasis	-	-
Depiquick Birch (DPG103)	Phase 3	Allergic Rhinoconjunctivitis	-	-
ABL001	Phase 3	Chronic Myelogenous Leukemia - Chronic Phase	-	-
Tobramycin inhalation powder	Phase 3	Pseudomonas Aeruginosa	-	-
MenACWY CRM	Phase 3	Meningococcal Infections	-	-
Canakinumab (ACZ885)	Phase 3	Cryopyrin-Associated Periodic Syndromes	-	-
Influenza vaccine	Phase 3	Influenza	-	-
Indacaterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
agomelatine	Phase 3	Major Depressive Disorder	-	-
Diclofenac sodium gel 1%	Phase 3	Muscle Soreness	-	-
Tiotropium 18 μg	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Imatinib	Phase 3	Chronic Myeloid Leukemia	-	-
TIV	Phase 3	Seasonal Influenza	-	-
Goserelin	Phase 3	Breast Cancer	-	-
Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1)	Phase 3	Serogroup B Meningococcal Meningitis	-	-
rMenB + OMV NZ vaccine	Phase 3	Meningococcal Disease	-	-
Ofatumumab approved dose	Phase 3	Relapsing Multiple Sclerosis (RMS)	-	-
VALSARTAN, VALSARTAN+HYDROCHLOROTHIAZIDE	Phase 3	Hypertension	-	-
Combined inactivated hepatitis A & recombinant hepatitis B	Phase 3	Meningococcal Disease	-	-
Vaxem Hib (Haemophilus influenzae type b (Hib) vaccine)	Phase 3	Haemophilus Influenzae Type b (Hib) Infection	-	-
Octreotide Long Acting Release	Phase 3	Chemotherapy-induced Diarrhea	-	-
Tetanus toxoid vaccine	Phase 3	Relapsing Multiple Sclerosis	-	-
Ritalin LA (methylphenidate hydrochloride extended release)	Phase 3	Attention Deficit/Hyperactivity Disorder	-	-
Secukinumab 150 mg s.c.	Phase 3	Plaque Psoriasis	-	-
Fevipiprant 150 mg	Phase 3	Nasal Polyps	-	-
LMF237 50/250 mg	Phase 3	Diabetes Mellitus, Type 2	-	-
Tifacogin	Phase 3	Pneumonia	-	-
Calcineurin inhibitors (CNI)	Phase 3	Liver Transplantation	-	-
Pelacarsen	Phase 3	Hyperlipoproteinemia (a)	-	-
indacaterol and glycopyrronium bromide (QVA149)	Phase 3	COPD	-	-
Tobramycin solution for inhalation 300 mg	Phase 3	Cystic Fibrosis	-	-
AIN457 150 mg	Phase 3	Moderate to Severe Chronic Plaque-Type Psoriasis	-	-
Tacrolimus (reduced tacrolimus)	Phase 3	Liver Transplant Recipient	-	-
Indacaterol 150 μg	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Votoplam (blinded)	Phase 3	Huntington Disease	-	-
recombinant interferon alfa	Phase 3	Leukemia	-	-
eltrombopag	Phase 3	Thrombocytopaenia	-	-
Sorafenib	Phase 3	Metastatic Renal Cell Carcinoma	-	-
Salmeterol/fluticasone (50/500 μg)	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Adjuvanted Trivalent Influenza Vaccine, 1 dose for non-naive subjects (day 1), two doses for naive subjects (day 1 and day 29)	Phase 3	Influenza	-	-
JDQ443	Phase 3	Non-Small Cell Lung Cancer	-	-
Zoledronic acid 5 mg solution	Phase 3	Osteoporosis	-	-
Cyclosporine A microemulsion	Phase 3	Chronic Plaque Psoriasis	-	-
RTH258/Brolucizumab	Phase 3	Neovascular Age-Related Macular Degeneration	-	-
Carbidopa/levodopa/entacapone	Phase 3	Parkinson's Disease	-	-
TIVc_LOT A	Phase 3	Prophylaxis: Influenza	-	-
secukinumab low dose	Phase 3	Moderate to Severe Chronic Plaque-type Psoriasis	-	-
Certican®	Phase 3	Renal Interstitial Fibrosis	-	-
Diclofenac Sodium Gel	Phase 3	Osteoarthritis of the Knee	-	-
Remibrutinib oral treatment	Phase 3	Relapsing Multiple Sclerosis	-	-
valsartan+amlodipine combination, valsartan, amlodipine	Phase 3	Hypertension	-	-
Telbivudine (LdT)	Phase 3	Chronic Hepatitis B	-	-
1 dose of Meningococcal (group B) multicomponent recombinant adsorbed vaccine	Phase 3	Meningococcal Disease	-	-
Lumiracoxib (drug)	Phase 3	Osteoarthritis, Hip	-	-
Pertuzumab	Phase 3	Advanced HER2+Breast Cancer	-	-
Recombinant meningococcal B + OMV NZ	Phase 3	Meningococcal Disease	-	-
Cytarabine	Phase 3	Acute Myeloid Leukemia	-	-
RTH258	Phase 3	Neovascular Age Related Macular Degeneration	-	-
ACZ885	Phase 3	TNF-receptor Associated Periodic Syndromes (TRAPS)	-	-
Tamoxifen	Phase 3	Advanced Metastatic Breast Cancer	-	-
Heparin	Phase 3	Embolism	-	-
OFC Infusion	Phase 3	Leukaemia, Lymphocytic, Chronic	-	-
rabies vaccine	Phase 3	Rabies Post-exposure Prophylaxis	-	-
Lansoprazole	Phase 3	Heartburn	-	-
Cell derived subunit trivalent nonadjuvanted vaccine	Phase 3	Influenza	-	-
irbesartan	Phase 3	Hypertension	-	-
Enteric-coated Mycophenolate sodium (EC-MPS), valsartan	Phase 3	De Novo Renal Transplantation	-	-
Lanzoprazole	Phase 3	Heartburn	-	-
Active Comparator	Phase 3	Alzheimer's Disease	-	-
EC-MPS	Phase 3	Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS	-	-
Brolucizumab 6mg	Phase 3	Neovascular Age-Related Macular Degeneration	-	-
Ruxolitinib (RUX)	Phase 3	Corticosteroid Refractory Acute Graft vs Host Disease	-	-
Canakinumab 150 mg	Phase 3	Acute Gout	-	-
GP2017 (adalimumab biosimilar)	Phase 3	Ankylosing Spondylitis	-	-
Meningococcal ACWY conjugate vaccine	Phase 3	Bacterial Meningitis	-	-
Labeled regime arm	Phase 3	Diabetic Macular Edema	-	-
Fluticasone/salmeterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Aliskiren 75 mg	Phase 3	Hypertension	-	-
exemestane	Phase 3	Post Menopausal Breast Cancer	-	-
Bosentan	Phase 3	Pulmonary Arterial Hypertension	-	-
Long-acting beta 2-agonist (LABA)	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
Valsartan + Amlodipine besilate	Phase 3	Hypertension	-	-
Budesonide	Phase 3	Asthma	-	-
Mycophenolic Acid (MPA)	Phase 3	Kidney Transplantation	-	-
First line DMT	Phase 3	Multiple Sclerosis	-	-
Iptcaopan 200 mg	Phase 3	Atypical Hemolytic Uremic Syndrome	-	-
Nilotinib	Phase 3	Gastrointestinal Stromal Tumors	-	-
Seasonal Influenza Vaccine	Phase 3	Influenza	-	-
Meningococcal B Recombinant vaccine rMenB+OMV NZ	Phase 3	Meningococcal Disease	-	-
Inclisiran	Phase 3	Familial Hypercholesterolemia - Homozygous	-	-
Everolimus and tacrolimus	Phase 3	Kidney Transplant	-	-
Famciclovir	Phase 3	Genital Herpes	-	-
Risedronate	Phase 3	Paget's Disease of Bone	-	-
Crizanlizumab (SEG101)	Phase 3	Sickle Cell Disease (SCD)	-	-
Pimecrolimus Cream 1%	Phase 3	Atopic Dermatitis	-	-
Daptomycin	Phase 3	Infections	-	-
VAL489	Phase 3	Pediatric Hypertension With or Without CKD	-	-
Salmeterol	Phase 3	Chronic Obstructive Pulmonary Disease	-	-
Prograf or Neoral	Phase 3	Kidney Transplantation	-	-
sacubitril/valsartan	Phase 3	Heart Failure With Preserved Ejection Fraction	-	-
Octreotide	Phase 3	Thymoma	-	-
Enalapril	Phase 3	Pediatric Heart Failure	-	-
valsartan plus hydrochlorothiazide	Phase 3	Hypertension	-	-
NVA237 50 µg and indacaterol 150 µg	Phase 3	Chronic Obstructive Pulmonary Disease (COPD)	-	-
ciclosporin	Phase 3	Severe Atopic Dermatitis	-	-
rofecoxib	Phase 3	Osteoarthritis	-	-
Pandemic influenza vaccine	Phase 3	Influenza	-	-
Secukinumab (150 mg)	Phase 3	Anklyosing Spondylitis	-	-
sulfonylurea (SU)	Phase 3	Type 2 Diabetes Mellitus (T2DM)	-	-
MMF	Phase 3	Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant	-	-
Octreotide acetate 30 mg suspension	Phase 3	Acromegaly	-	-
Losartan	Phase 3	Hypertension; Hypertrophy, Left Ventricular	-	-
[68Ga]Ga-PSMA-11	Phase 3	Prostatic Neoplasms	-	-
MF59-eH1N1	Phase 3	Influenza	-	-
Calcium and vitamin D supplements	Phase 3	Paget's Disease of Bone	-	-
MF59 adjuvanted trivalent subunit influenza vaccine (aTIV)	Phase 3	Influenza	-	-
octreotide LAR 30mg	Phase 3	Acromegaly	-	-
Xylometazoline	Phase 3	Common Cold	-	-
Aliskiren 300 mg	Phase 3	Hypertension	-	-
AIN457 6 mg/kg i.v.	Phase 3	Psoriatic Arthritis	-	-
basiliximab	Phase 3	Liver Transplantation	-	-
valsartan+amlodipine combination	Phase 3	Hypertension	-	-
Remibrutinib	Phase 3	Relapsing Multiple Sclerosis	-	-
Telbivudine	Phase 3	Hepatitis B Virus	-	-
Meningococcal ACWY Polysaccharide Vaccine	Phase 3	Meningococcal Meningitis	-	-
Pimecrolimus	Phase 3	Atopic Dermatitis	-	-
Depigoid	Phase 3	Allergic Asthma	-	-
Bosutinib	Phase 3	Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive	-	-
Rivastigmine 5 cm^2	Phase 3	Alzheimer Disease	-	-
simvastatin	Phase 3	Essential Hypertension	-	-
Secukinumab (75 mg)	Phase 3	Ankylosing Spondylitis	-	-
onasemnogene abeparvovec	Phase 3	Spinal Muscular Atrophy (SMA)	-	-
Leuprolide	Phase 3	Breast Cancer	-	-
brolucuzumab 6 mg IVT	Phase 3	Age-Related Macular Degeneration	-	-
Ofatumumab	Phase 3	Relapsing Multiple Sclerosis	-	-
Deferasirox	Phase 3	Beta-thalassemia	-	-
ACZ885 150 mg (Canakinumab)	Phase 3	Systemic Juvenile Idiopathic Arthritis (SJIA)	-	-
canakinumab	Phase 3	NALP3 Mutation	-	-
Candesartan+HCTZ - Phase 1	Phase 3	Hypertension	-	-
TRI476	Phase 3	Partial Onset Seizures	-	-
Ansastrozole	Phase 3	Early Breast Cancer	-	-
Aliskiren/amlodipine 300/10 mg tablet	Phase 3	Moderate to Severe Hypertension	-	-
HCD122	Phase 2	Non-Hodgkin's Lymphoma	-	-
Alcohol-free dexamethasone mouth rinse (Stomatitis sub-study)	Phase 2	Hormone Receptor Positive Breast Cancer	-	-
Conventional Therapy	Phase 2	Non-infectious Intermediate Uveitis	-	-
Surface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008	Phase 2	Influenza	-	-
Meningococcal (group B) multicomponent recombinant adsorbed vaccine.	Phase 2	Meningococcal Disease	-	-
GSK2110183 (afuresertib)	Phase 2	Cancer	-	-
Octreotide (Immediate release)	Phase 2	Peritoneal Neoplasms	-	-
TMZ	Phase 2	Medulloblastoma	-	-
decitabine	Phase 2	Myelodysplastic Syndromes	-	-
QAV680	Phase 2	Seasonal Allergic Rhinitis	-	-
Midostaurin (PKC412)	Phase 2	Leukemia	-	-
VAK694; Alutard Avanz SQ	Phase 2	Seasonal Allergic Rhinitis	-	-
BION-1301 Single Dose	Phase 2	IgA Nephropathy	-	-
QAW039 capsules once daily for 28 days	Phase 2	Persistent Asthma	-	-
Mycophenolic Acid	Phase 2	Kidney Transplantation	-	-
MenACWY-TT	Phase 2	Meningococcal Disease	-	-
RKI983A	Phase 2	Glaucoma	-	-
BKM120	Phase 2	PI3K Pathway Activated Tumors	-	-
Treosulfane	Phase 2	Prostate Cancer	-	-
hATG	Phase 2	Aplastic Anemia	-	-
QGE031	Phase 2	Allergic Asthma	-	-
Adjuvant endocrine therapy	Phase 2	Breast Cancer	-	-
JSB462	Phase 2	Prostatic Cancer, Castration-Resistant	-	-
LTP	Phase 2	Healthy Volunteers, Pulmonary Arterial Hypertension	-	-
ITU512	Phase 2	Sickle Cell Disease	-	-
BYM338 active drug	Phase 2	Cachexia	-	-
LDK378	Phase 2	Non-Small Cell Lung Cancer	-	-
Deferasirox dispersable tablet (DT)	Phase 2	Transfusion-dependent Thalassemia	-	-
Aliskiren 3.125 mini-tablets	Phase 2	Hypertension	-	-
Fluticasone 250 mcg	Phase 2	Asthma	-	-
75 µg indacaterol maleate (LB)	Phase 2	Asthma	-	-
KAF156	Phase 2	Uncomplicated Plasmodium Falciparum Malaria	-	-
Meningococcal B vaccine	Phase 2	Meningococcal Meningitis	-	-
68Ga-PSMA-11	Phase 2	Metastatic Castration-Resistant Prostate Cancer (mCRPC)	-	-
Influenza Vaccine, Formulation 2008-2009	Phase 2	Seasonal Influenza	-	-
rMenB	Phase 2	Meningococcal Disease	-	-
Pelacarsen (TQJ230) 80mg	Phase 2	Aortic Stenosis	-	-
MCS110	Phase 2	Pigmented Villonodular Synovitis	-	-
Omalizumab 75-375 mg	Phase 2	Chronic Urticaria	-	-
Three 1 mL doses of Rabies vaccine and two JE vaccine	Phase 2	Rabies	-	-
QAX028	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
CGF166	Phase 2	Unilateral Severe to Profound Hearing Loss OR Bilateral Severe to Profound Hearing Loss	-	-
MF59 adjuvanted H5N1 influenza vaccine	Phase 2	Influenza	-	-
EYU688	Phase 2	Dengue	-	-
DII235	Phase 2	Lipoprotein Disorder	-	-
LEZ763	Phase 2	Type II Diabetes	-	-
Indacaterol maleate 400 μg	Phase 2	Asthma	-	-
Secukinumab 10 mg/kg	Phase 2	Dry Eye	-	-
EGF816	Phase 2	Advanced Non-small Cell Lung Cancer	-	-
cyclosporine (reduced exposure) / everolimus	Phase 2	Kidney Transplantation	-	-
AEE788	Phase 2	Brain and Central Nervous System Tumors	-	-
MenACWY-CRM197	Phase 2	Meningococcal Disease	-	-
GIA632	Phase 2	Atopic Dermatitis	-	-
CPK850	Phase 2	Retinitis Pigmentosa	-	-
BAF312 solution	Phase 2	Hemorrhagic Stroke	-	-
Certoparin 3,000 IU Once Daily	Phase 2	Renal Insufficiency	-	-
QBW276	Phase 2	Pulmonary Cystic Fibrosis	-	-
short acting β2- agonist	Phase 2	COPD	-	-
valtorcitabine	Phase 2	Hepatitis B	-	-
LNA043	Phase 2	Osteoarthritis	-	-
LOU064 Arm 1	Phase 2	Chronic Spontaneous Urticaria	-	-
RAD001(everolimus)	Phase 2	Carcinoma	-	-
68Ga-FAP-2286	Phase 2	Solid Tumor	-	-
LFG316	Phase 2	Paroxysmal Nocturnal Hemoglobinuria	-	-
Sevelamer HCl	Phase 2	Chronic Kidney Disease	-	-
Seasonal Influenza Vaccine (MF59C.1)	Phase 2	Seasonal Influenza	-	-
MIJ821 Subcutaneous Injection 1 mg	Phase 2	Treatment-Resistant Depression	-	-
Dovitinib (TKI258)	Phase 2	Tumor Pathway Activations Inhibited by Dovitinib	-	-
sacubitril/valsartan (LCZ696)	Phase 2	Hypertension	-	-
NVA237 12.5 µg once daily	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
Glucocorticoids	Phase 2	ANCA Associated Vasculitis (AAV)	-	-
Glycopyrronium bromide 25ug	Phase 2	Asthma	-	-
XXB750 drug	Phase 2	Resistant Hypertension	-	-
XBD173	Phase 2	Anxiety Disorders	-	-
INE963	Phase 2	Uncomplicated Plasmodium Falciparum Malaria	-	-
CFZ533 - MMF - CS	Phase 2	Kidney Transplant Rejection	-	-
LCZ696A	Phase 2	Pharmacokinetics	-	-
alb-interferon alfa 2b	Phase 2	Chronic Hepatitis C	-	-
CFZ533	Phase 2	Lupus Nephritis	-	-
Panobinostat (LBH589)	Phase 2	Myelodysplastic Syndromes	-	-
Serelaxin	Phase 2	Labor, Induced	-	-
Rapcabtagene autoleucel	Phase 2	Idiopathic Inflammatory Myopathies	-	-
AMN107- NILOTINIB	Phase 2	Gastrointestinal Stromal Tumors (GIST)	-	-
Sumatriptan	Phase 2	Migraine	-	-
Oxybutynin	Phase 2	Healthy Volunteers	-	-
QAV680 + Cetirizine	Phase 2	Allergic Rhinitis	-	-
Influenza vaccine surface antigen adjuvanted with MF59	Phase 2	Pandemic Influenza Disease	-	-
RLX030 (serelaxin)	Phase 2	Chronic Heart Failure	-	-
Naproxen	Phase 2	Osteoarthritis	-	-
Tropifexor (LJN452)	Phase 2	Non-alcoholic Steatohepatitis (NASH)	-	-
zigakibart	Phase 2	Immunoglobulin A Nephropathy (IgAN)	-	-
VHB937	Phase 2	Amyotrophic Lateral Sclerosis (ALS)	-	-
Iscalimab	Phase 2	Sjogren's Syndrome	-	-
LXE408	Phase 2	Chagas Disease	-	-
Indacaterol 27.5 mcg	Phase 2	Asthma	-	-
SPP100	Phase 2	Hypertension	-	-
PTK787	Phase 2	Wet Age-Related Macular Degeneration	-	-
Enzalutamide	Phase 2	Advanced Solid Tumor	-	-
Prednisone	Phase 2	Lupus Nephritis	-	-
LBH589	Phase 2	Lymphoma	-	-
ACZ885 (investigational)	Phase 2	Rheumatoid Arthritis	-	-
CFZ533 active - Cohort 1	Phase 2	Primary Sjögren's Syndrome	-	-
ARV-766 Part A&B	Phase 2	Prostate Cancer Metastatic	-	-
Anastrozole	Phase 2	Breast Cancer	-	-
NGI226	Phase 2	Achilles Tendinopathy	-	-
AEB071	Phase 2	Uveitis	-	-
Core Study: Deferasirox	Phase 2	Transfusional Iron Overload	-	-
AQW051 2 mg (single and multiple doses)	Phase 2	Schizophrenia Disorders	-	-
serogroup B meningococcal vaccine	Phase 2	Meningococcal Disease	-	-
AIN457A	Phase 2	Ankylosing Spondylitis	-	-
Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy	Phase 2	Attention Deficit Hyperactivity Disorder	-	-
AFQ056	Phase 2	Parkinson's Disease	-	-
Patupilone	Phase 2	Metastatic Hormone Refractory Prostate Cancer	-	-
rapcabtagene autoleucel (YTB323)	Phase 2	Progressive Multiple Sclerosis	-	-
HSC835	Phase 2	Acute Myelocytic Leukemia	-	-
PDR001	Phase 2	Melanoma	-	-
QAX576	Phase 2	Asthma	-	-
Indacaterol 300μg	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
LIK066	Phase 2	Elevated Body Mass Index	-	-
TKI258	Phase 2	Solid Tumors and Advanced Endometrial Cancer	-	-
QVM149 150/50/80 μg o.d.	Phase 2	Asthma	-	-
BHQ880	Phase 2	Smoldering Multiple Myeloma	-	-
DNK333	Phase 2	Irritable Bowel Syndrome With Diarrhea (IBS-D)	-	-
Indacaterol (QAB149)	Phase 2	COPD	-	-
balicatib (AAE581)	Phase 2	Knee Osteoarthritis	-	-
Iptacopan (part 1)	Phase 2	Lupus Nephritis	-	-
MF59-eH5N1	Phase 2	Pandemic	-	-
UNR844-Cl	Phase 2	Presbyopia	-	-
Zoledronic Acid; Letrozole	Phase 2	Breast Cancer	-	-
epothilone b	Phase 2	Ovarian Neoplasms	-	-
PTK787/ZK 222584	Phase 2	Von Hippel-Lindau Disease	-	-
Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.	Phase 2	Invasive Meningococcal Disease	-	-
tisagenlecleucel	Phase 2	Follicular Lymphoma	-	-
Fluad H5N1 Pandemic Influenza Vaccine	Phase 2	Prophylaxis of Avian Influenza Vaccine	-	-
combined diphtheria,tetanus,pertussis+polio+Hepatitis B+Haemophilus influenzae B vaccine	Phase 2	Meningococcal Infections	-	-
BEZ235 (Stage 1)	Phase 2	Pancreatic Neuroendocrine Tumors (pNET)	-	-
Meningococcal Vaccine	Phase 2	Meningococcal Disease	-	-
MenABCWY+OMV	Phase 2	Meningococcal Disease	-	-
AFQ056 with L-dopa	Phase 2	Parkinson's Disease	-	-
ICL670, deferoxamine	Phase 2	Anemia, Sickle Cell	-	-
IGE025	Phase 2	Chronic Idiopathic Urticaria	-	-
DFV890	Phase 2	Coronary Heart Disease	-	-
CMK389	Phase 2	Atopic Dermatitis	-	-
Nilotinib followed by treatment-free	Phase 2	Chronic Myelogenous Leukemia	-	-
[68Ga]Ga-NeoB	Phase 2	Breast Cancer	-	-
AUY922	Phase 2	Non-small-cell Lung Cancer	-	-
TCH346	Phase 2	Amyotrophic Lateral Sclerosis	-	-
SBR759	Phase 2	Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy	-	-
STI571 (Glivec®)	Phase 2	Prostatic Neoplasm	-	-
MenC-CRM LIQ	Phase 2	Meningococcal Disease	-	-
LEE011	Phase 2	Teratoma	-	-
Simulect®	Phase 2	Renal Transplantation	-	-
NVGH Vi-CRM197	Phase 2	Typhoid Fever	-	-
MenACWY-CRM conjugate vaccine, adjuvanted	Phase 2	Prevention of Meningococcal Disease	-	-
VAK694	Phase 2	Allergic Rhinitis	-	-
BFH772 1% ointment	Phase 2	Erythemato-telangiectatic Rosacea	-	-
BGT226	Phase 2	Solid Tumors	-	-
Docetaxel	Phase 2	Advanced Gastric Cancer	-	-
Cyclosporine A	Phase 2	Atopic Dermatitis	-	-
Dexamethasone based mouthwash	Phase 2	Advanced Breast Cancer	-	-
SMC021	Phase 2	Health Postmenopausal Women	-	-
NVA237 100 µg	Phase 2	Chronic Obstructive Pulmonary Disease (COPD)	-	-
KAE609	Phase 2	Malaria	-	-
Vi-CRM197 vaccine	Phase 2	Typhoid Fever	-	-
Infliximab	Phase 2	Crohn's Disease	-	-
SAF312A	Phase 2	Postoperative Pain	-	-
indacaterol maleate / mometasone furoate	Phase 2	Asthma	-	-
Canakinumab (investigational)	Phase 2	Rheumatoid Arthritis	-	-
mometasone furoate	Phase 2	Asthma	-	-
GSK2118436	Phase 2	Cancer	-	-
Cipargamin	Phase 2	Uncomplicated Plasmodium Falciparum Malaria	-	-
BZF961	Phase 2	Hepatitis C	-	-
Capmatinib	Phase 2	Carcinoma, Non-Small-Cell Lung	-	-
ABL001/Asciminib	Phase 2	Chronic Myeloid Leukemia (CML)	-	-
CLR325	Phase 2	Chronic Stable Heart Failure	-	-
H5N1 pandemic Influenza vaccine 3.75µg	Phase 2	Pandemic H5N1 Influenza	-	-
Dexamethasone	Phase 2	Immune Thrombocytopenia (ITP)	-	-
Evolocumab	Phase 2	Atherosclerotic Cardiovascular Disease	-	-
TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt)	Phase 2	Parkinson's Disease	-	-
Rapcabtagene autoleucel single agent	Phase 2	Chronic Lymphocytic Leukemia	-	-
RFB002	Phase 2	Diabetic Macular Edema	-	-
[177Lu]Lu-DOTA-TATE	Phase 2	Extensive Stage Small Cell Lung Cancer	-	-
Indacaterol acetate	Phase 2	Asthma	-	-
MenACWY polysaccharide vaccine	Phase 2	Meningococcal Meningitis	-	-
Iloperidone crystalline formulation	Phase 2	Schizophrenia	-	-
CNP520	Phase 2	Alzheimer's Disease	-	-
Mometasone furoate/formoterol fumarate (MFF)	Phase 2	Asthma	-	-
LDE225	Phase 2	Basal Cell Carcinoma	-	-
BVS857	Phase 2	Spinal and Bulbar Muscular Atrophy	-	-
Montelukast	Phase 2	Asthma	-	-
LHW090	Phase 2	Patients, Resistant Hypertension	-	-
QMF149 Twisthaler®	Phase 2	Asthma	-	-
NIC002	Phase 2	Smokers	-	-
RAD001, Letrozole 2.5mg	Phase 2	Breast Neoplasm	-	-
LCI699	Phase 2	Hypertension	-	-
IV Artesunate	Phase 2	Severe Malaria	-	-
Aliskiren/ Valsartan	Phase 2	Hypertension	-	-
MAS825	Phase 2	COVID-19 Pneumonia, Impaired Respiratory Function	-	-
QBW251	Phase 2	Pulmonary Disease, Chronic Obstructive	-	-
BYM338	Phase 2	Skeletal Muscle	-	-
DNK333 100 mg twice daily	Phase 2	Chronic Obstructive Pulmonary Disease	-	-
ECF843	Phase 2	Dry Eye	-	-
LBH589 (panobinostat)	Phase 2	Relapse/Refractory Multiple Myeloma	-	-
LFF571	Phase 2	Moderate Clostridium Difficile Infection	-	-
LLG783	Phase 2	Peripheral Artery Disease (PAD); Intermittent Claudication	-	-
KRP203 - 1.2mg	Phase 2	Subacute Cutaneous Lupus Erythematosus	-	-
Panobinostat/LBH589	Phase 2	Refractory Leukemia	-	-
Fenofibrate	Phase 2	Non Familial Chylocmicronemia Syndrome (Non-FCS)	-	-
Seasonal flu vaccine	Phase 2	Seasonal Influenza	-	-
STI571 400 mg	Phase 2	Philadelphia Positive Chronic Myeloid Leukemia	-	-
bortezomib	Phase 2	Multiple Myeloma	-	-
AIN 457	Phase 2	Non-infectious Uveitis	-	-
CJM112	Phase 2	Hidradenitis Suppurativa (Acne Inversa)	-	-
Entacapone	Phase 2	Parkinson's Disease	-	-
STI571	Phase 2	Systemic Sclerosis, Scleroderma	-	-
Surface Antigen, Inactivated, (Adjuvanted with MF59C.1), form. 2006-07	Phase 2	Influenza	-	-
H5N1 Influenza Vaccine	Phase 2	Prophylaxis of Avian Influenza	-	-
VAY736 1ml PFS	Phase 2	Sjögrens Disease	-	-
DTaP-Hib-IPV	Phase 2	Meningococcal Disease	-	-
AHU377	Phase 2	Hypertension	-	-
Investigational new drug, company code: BGG492	Phase 2	Partial Onset Seizures	-	-
INC280	Phase 2	Non-small Cell Lung Cancer	-	-
Deferasirox granule formulation	Phase 2	Transfusion-dependent Anemia	-	-
Deferasirox dispersible tablet	Phase 2	Chronic Iron Overload Due to Transfusion-dependant Anemias	-	-
Daunorubicin	Phase 2	Acute Leukaemia	-	-
AMO959	Phase 2	PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy	-	-
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg	Phase 2	Heartburn	-	-
Group B Streptococcus Trivalent Vaccine	Phase 2	Streptococcal Infection	-	-
MenACWY-CRM Vaccine	Phase 2	Prevention of Meningococcal Disease	-	-
Influenza Trivalent Inactivated Vaccines	Phase 2	FLU	-	-
Asciminib Pediatric formulation group	Phase 2	Myeloid Leukemia, Philadelphia Positive	-	-
Adjuvanted H5N1 pandemic influenza vaccine	Phase 2	Pandemic H5N1 Influenza	-	-
Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine	Phase 2	Meningococcal Disease	-	-
MenABCWY	Phase 2	Meningococcal Disease	-	-
Flu Vaccine Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2008-2009	Phase 2	Influenza	-	-
BGG492	Phase 2	Photosensitive Epilepsy	-	-
Group B streptococcus vaccine	Phase 2	Streptococcal Infections	-	-
Novartis Meningococcal (MenACWY-CRM) vaccine	Phase 2	Meningococcal Disease	-	-
MenC-CRM	Phase 2	Meningococcal Meningitis	-	-
MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation)	Phase 2	Prevention of Meningococcal Disease	-	-
SOM230 s.c.	Phase 2	Cushing's Syndrome	-	-
Panitumumab	Phase 2	Cancer	-	-
Abiraterone	Phase 2	Metastatic Hormone-sensitive Prostate Cancer	-	-
Indacaterol acetate 75 μg	Phase 2	Asthma	-	-
Adjuvanted Trivalent Influenza Virus Vaccine (aTIV)	Phase 2	Human Influenza	-	-
Buparlisib	Phase 2	Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma	-	-
Eplerenone	Phase 2	Essential Hypertension	-	-
Everolimus 10 mg	Phase 2	Islet Cell Carcinoma	-	-
Bridging Therapy	Phase 2	Non-Hodgkin Lymphoma	-	-
Nazartinib	Phase 2	Advanced Solid Tumors Which Are cMET-dependent	-	-
LRX712	Phase 2	Osteoarthritis (OA)	-	-
LAG525	Phase 2	Triple-negative Breast Cancer	-	-
Deferasirox DFX, DT	Phase 2	Low and Int 1-risk Myelodysplastic Syndrome	-	-
DTIC	Phase 2	Melanoma	-	-
Rabbit ATG	Phase 2	Aplastic Anemia	-	-
CSJ148	Phase 2	HCMV	-	-
SAF312	Phase 2	Postoperative Ocular Pain After PRK Surgery	-	-
Imatinib 600mg/day (Glevec is the brand name for imatinib)	Phase 2	Gastrointestinal Stromal Tumors	-	-
Votoplam	Phase 2	Huntington Disease	-	-
Surface antigen inactivated influenza vaccine	Phase 2	Influenza	-	-
Tulmimetostat	Phase 2	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	-	-
PTK787/ZK 222584 (vatalanib)	Phase 2	Tumors	-	-
Aliskiren 150 mg	Phase 2	Heart Failure	-	-
CAD106	Phase 2	Alzheimer Disease	-	-
LXH254	Phase 2	Melanoma	-	-
GVV858	Phase 2	Advanced HR+/HER2- Breast Cancer	-	-
AAE581	Phase 2	Osteoporosis	-	-
Trivalent subunit inactivated flu vaccine, Formulation 2010-2011	Phase 2	Seasonal Influenza	-	-
Pandemic influenza vaccine + seasonal influenza vaccine /pandemic influenza vaccine	Phase 2	Influenza	-	-
AUY922 2 mg/m2	Phase 2	Breast Cancer	-	-
aTIV	Phase 2	Human Influenza	-	-
Group B Streptococcus Trivalent Vaccine - 20/20/20 μg	Phase 2	Streptococcal Infections	-	-
LCQ908A	Phase 2	Type 2 Diabetes Mellitus	-	-
CTL019 T-cells	Phase 2	B-cell Acute Lymphoblastic Leukemia	-	-
Deferasirox (ICL670)	Phase 2	Chronic Anemia	-	-
MF59C.1-adjuvanted subunit influenza vaccine	Phase 2	Seasonal Influenza	-	-
NSAI: Letrozole or Anastrazole	Phase 2	Breast Cancer	-	-
Investigational Treatment	Phase 2	External Genital Warts	-	-
rabbit anti-thymocyte globulin (r-ATG)	Phase 2	Severe Aplastic Anemia (SAA)	-	-
Men ACWY CRM	Phase 2	Meningococcal Disease	-	-
GXV813	Phase 2	Schizophrenia	-	-
Methotrexate	Phase 2	Rheumatoid Arthritis	-	-
DYP688	Phase 2	Metastatic Uveal Melanoma	-	-
LJN452	Phase 2	Primary Bile Acid Diarrhea	-	-
FGF401	Phase 2	Hepatocellular Carcinoma (HCC)	-	-
Asciminib add-on	Phase 2	CML	-	-
Indacaterol 150 μg via the Concept1 dry-powder inhaler	Phase 2	Asthma	-	-
Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008	Phase 2	Influenza	-	-
Ranibizumab 0.3 mg	Phase 2	Diabetic Macular Edema	-	-
SOM230	Phase 2	Dumping Syndrome	-	-
Secukinmab	Phase 2	Rheumatoid Arthritis	-	-
225Ac-PSMA-R2	Phase 2	Prostate Cancer	-	-
Alum	Phase 2	Alzheimer's Disease	-	-
[177Lu]Lu-PSMA-617	Phase 2	Metastatic Castration-Resistant Prostate Cancer (mCRPC)	-	-
Anecortave Acetate Sterile Suspension, 30 mg/mL	Phase 2	Open-angle Glaucoma	-	-
Letrozole OR Anastrozole	Phase 2	Breast Cancer	-	-
Nepafenac Ophthalmic Suspension, 0.3%	Phase 2	Cataract	-	-
KAE609 (Cipargamin)	Phase 2	Uncomplicated Plasmodium Falciparum Malaria	-	-
Difluprednate 0.05% ophthalmic emulsion	Phase 2	Dry Eye Disease	-	-
anecortave acetate	Phase 2	AMD	-	-
RHH646	Phase 2	Osteoarthritis, Knee	-	-
carboplatin	Phase 2	Advanced Triple Negative Breast Cancer (TNBC) With High TAMs	-	-
ARPI: Abiraterone	Phase 2	Metastatic Castration Resistant Prostate Cancer (mCRPC)	-	-
high-dose imatinib	Phase 2	CML	-	-
indacaterol/glycopyrrolate	Phase 2	Chronic Obstructive Pulmonary Disease (COPD)	-	-
BFH772	Phase 2	Psoriasis	-	-
ECI830	Phase 2	Advanced HR+/HER2- Breast Cancer	-	-
Atrasentan	Phase 2	IgA Nephropathy	-	-
Influenza Trivalent Inactivated vaccines Novartis	Phase 2	Influenza	-	-
Lapatinib/nab-Paclitaxel	Phase 2	Neoplasms, Breast	-	-
Lymphodepleting chemotherapy	Phase 2	Diffuse Large B-cell Lymphoma (DLBCL)	-	-
TIN816 70 mg lyophilisate powder	Phase 2	Acute Kidney Injury Due to Sepsis	-	-
APL180	Phase 2	Coronary Heart Disease	-	-
CSJ117	Phase 2	Pulmonary Disease, Chronic Obstructive	-	-
Deferasirox and Deferoxamine	Phase 2	Cardiac Iron Overload	-	-
NIM811	Phase 2	Chronic Hepatitis C Genotype-1 Relapse	-	-
BYL719	Phase 2	Breast Cancer	-	-
Coartem	Phase 2	Acute Uncomplicated Plasmodium Falciparum Malaria	-	-
Colchicine	Phase 2	Gout	-	-
LKA651	Phase 2	Diabetic Macular Edema	-	-
Terlipressin acetate	Phase 2	Compensated Cirrhosis and Portal Hypertension	-	-
Prednisolone	Phase 2	Giant Cell Arteritis	-	-
RAF265	Phase 2	Metastatic Melanoma	-	-
Aggripal®	Phase 2	Human Influenza	-	-
AQW051	Phase 2	Dyskinesias	-	-

Seasonal Allergic Rhinitis

2 drugs in this indication

Neovascular Age-related Macular Degeneration

1 drug in this indication

Chronic Plaque Type Psoriasis

1 drug in this indication

Peritoneal Neoplasms

1 drug in this indication

Cancer

1 drug in this indication

Myelodysplastic Syndromes

1 drug in this indication

Hormone Receptor Positive Breast Cancer

1 drug in this indication

Pathological Myopia

1 drug in this indication

Renal Interstitial Fibrosis

1 drug in this indication

Non-Small Cell Lung Cancer

1 drug in this indication

Non-infectious Intermediate Uveitis

1 drug in this indication

Meningococcal Disease

1 drug in this indication

Prostatic Neoplasms

1 drug in this indication

Medulloblastoma

1 drug in this indication

Leukemia

1 drug in this indication

Melanoma

1 drug in this indication

Influenza

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Novartis AG

Market Overview

NVS News

Catalyst Timeline

BION-1301 Single Dose Phase 2 Results Expected

Remibrutinib Phase 3 Results Expected

CPK850 Phase 2 Results Expected

Pipeline & FDA Submissions

Competitive Positions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals